Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events

  Events

November 2012
Scientific News
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
08 Nov 2012 - 09 Nov 2012
The Boston Park Plaza Hotel & Towers, Boston, MA
2nd Healthcare Centers of Excellence Summit
More information
08 Nov 2012 - 09 Nov 2012
The Boston Park Plaza Hotel & Towers, Boston, MA
Bariatric Centers Executive Leadership Conference
More information
08 Nov 2012 - 09 Nov 2012
The Boston Park Plaza Hotel & Towers, Boston, MA
Neuroscience & Stroke Centers Executive Leadership Conference
More information
08 Nov 2012 - 08 Nov 2012
Odinsgatan 28, Gothenburg
1 day Quality control of qPCR in mol. diagnostics
More information
2nd World Congress on Cell Science & Stem Cell Research
12 Nov 2012 - 14 Nov 2012
Hilton San Antonio Airport, USA
2nd World Congress on Cell Science & Stem Cell Research
More information
World CDx Summit
12 Nov 2012 - 15 Nov 2012
Boston, USA
World CDx Summit
More information
12 Nov 2012 - 14 Nov 2012
Shanghai Everbright International Hotel
Conference on Instrumentations and Biotechnologies 2012
More information
International Conference on Genetic Syndromes and Gene Therapy
19 Nov 2012 - 21 Nov 2012
Hilton Hotel, San Antonio Airport, USA
International Conference on Genetic Syndromes and Gene Therapy
More information


Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!